期刊文献+

Amplifi cations of NCOA3 gene in colorectal cancers in a Chinese population 被引量:1

Amplifi cations of NCOA3 gene in colorectal cancers in a Chinese population
下载PDF
导出
摘要 AIM: To investigate the copy number variation of NACO3 gene in colorectal cancer (CRC) and its correlation with tumor progression. METHODS: A total of 142 samples of case-matched CRC tissues and adjacent normal tissues were obtained from patients undergoing bowel resection. Quantitative real-time polymerase chain reaction method was used to investigate the copy number variations of NCOA3 as well as gene expression in the collected tissues. RESULTS: Copy number gains of NCOA3 were detected in 39 CRC samples (27.5%) and were correlatedwith tumor progression (χ2 = 6.42, P = 0.0112). Moreover, there was a positive correlation between copy number gain and mRNA over-expression of NCOA3 in CRCs (P = 0.0023). Expression level of NCOA3 mRNA was also enhanced in the CRC samples with unaltered copy numbers (3.85 ± 1.23 vs 2.71 ± 0.64, P < 0.01). CONCLUSION: Sporadic colorectal cancers exhibit different mechanisms of NCOA3 regulation. AIM: To investigate the copy number variation of NACO3 gene in colorectal cancer (CRC) and its correlation with tumor progression. METHODS: A total of 142 samples of case-matched CRC tissues and adjacent normal tissues were obtained from patients undergoing bowel resection. Quantitative real-time polymerase chain reaction method was used to investigate the copy number variations of NCOA3 as well as gene expression in the collected tissues. RESULTS: Copy number gains of NCOA3 were detected in 39 CRC samples (27.5%) and were correlatedwith tumor progression (χ2 = 6.42, P = 0.0112). Moreover, there was a positive correlation between copy number gain and mRNA over-expression of NCOA3 in CRCs (P = 0.0023). Expression level of NCOA3 mRNA was also enhanced in the CRC samples with unaltered copy numbers (3.85 ± 1.23 vs 2.71 ± 0.64, P 〈 0.01). CONCLUSION: Sporadic colorectal cancers exhibit different mechanisms of NCOA3 regulation.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第8期855-860,共6页 世界胃肠病学杂志(英文版)
基金 Supported by Fundamental Research Plan of Shenzhen City, No. JC201005260215A
关键词 大肠癌 基因扩增 中国人口 阳离子 基因拷贝数 聚合酶链反应 mRNA CRC Colorectal cancer NCOA3 Gene copy num-ber Gene expression Tumor progression
  • 相关文献

参考文献1

二级参考文献69

  • 1Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58: 1008-15.
  • 2Harbour, JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000;14: 2393-409.
  • 3Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005;24: 2810-26.
  • 4Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol 2005;15: 319-26.
  • 5Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y,Hortobagyi GN, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347: 1566-75.
  • 6Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, et al. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 2003;82:11-6.
  • 7Dhillon NK, Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene 2002;21: 4626-34.
  • 8Grimberg A. Mechanisms by which IGF-I may promote cancer.Cancer Biol Ther 2003;2: 630-5.
  • 9Oh A, List H J, Reiter R, Mani A, Zhang Y, Gehan E, et al. The nuclear receptor coactivator AIB 1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.Cancer Res 2004;64: 8299-308.
  • 10Zhou G, Hashimoto Y, Kwak I, Tsai SY, Tsai MJ. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 2003;23:7742-55.

共引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部